Intas Pharmaceuticals Limited Mycophenolate Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Mycophenolate Export Records India — #1 Exporter, 454 Shipments, $22.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Mycophenolate

India Pharmaceutical Trade Intelligence

$334.4M167 Suppliers100 CountriesHS 30049099

ExportsIndia → UNITED STATES76.6%India → AUSTRALIA6.1%

ImportsGERMANY → India$999.6M ITALY → India$223.6M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: EVERSANA LIFE

Intas Pharmaceuticals Limited — Mycophenolate Exporter #1 | $23.4M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Mycophenolate Exporter Profile

Indian Pharmaceutical Exporter · #1 for Mycophenolate · $23.4M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #1 Indian exporter of Mycophenolate with $23.4M in export value and 454 verified shipments. Intas Pharmaceuticals Limited holds a 6.8% market share in Mycophenolate exports across 24 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Mycophenolate Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Mycophenolate export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Mycophenolate?

Country	Value	Shipments	Share
UNITED STATES	$7.3M	158	46.0%
BRAZIL	$1.6M	36	9.9%
THAILAND	$1.6M	40	9.9%
AUSTRALIA	$1.1M	31

Who Are the Top Buyers of Mycophenolate from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$4.6M	98
EVERSANA LIFE SCIENCES SERVICES LLC	UNITED STATES	$1.4M	29
TO THE ORDER	NETHERLANDS	$998.6K	44
EVERSANA LIFE SCIENCES SERVICESLLC	UNITED STATES	$945.1K	21
ACCORD FARMACUTICA LTDA	BRAZIL	$900.9K	19
BERLIN PHARMACEUTICALINDUSTRYCO.LTD	THAILAND	$597.7K	13
BERLIN PHARMACEUTICAL INDUSTRY CO.L	THAILAND	$446.9K	9
APOTEX PTY LTD	AUSTRALIA	$410.8K	10
ACCORD UK	UNITED KINGDOM	$390.9K	20
ACCORD HEALTHCARE POLSKA SP ZOO MAGAZYN IMPORTERA UL LUTOMIERSKA	POLAND	$376.0K	9

Intas Pharmaceuticals Limited supplies Mycophenolate to 70 buyers globally. The largest buyer is EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES), followed by EVERSANA LIFE SCIENCES SERVICES LLC (UNITED STATES) and TO THE ORDER (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Mycophenolate Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS AND MEDI MYCOPHENOLATE MOFE	$639.4K	14
PHARMA DRUGS & MEDI MYCOPHENOLATE MOFETIL USP 500MG500T(US) AS PER INVOICE	$498.8K	11
PHA.DRU & MEDI, MYCOPHENOLATE MOF CAP US	$487.9K	11
PHA.DRU & MEDI, MYCOPHENOLATE MOFETIL USP 500MG500T(US) MYCOPHENOLATE MOFETIL T 500MG EACH FILM COATED TABLET	$414.9K	11
PHARMA DRUGS & MEDI MYCOPHENOLATE MOFETI	$400.0K	8
PHR DRUGS&MEDI MYCOPHENOLATE MOFETIL USP	$400.0K	8
PHA.DRU & MEDI, MYCOPHENOLATE MOFETIL US	$385.7K	8
PHARMA DRUGS & MEDI MYCOPHENOLATE MOF CA	$300.0K	6
PHR DRUGS & MEDI MYCOPHEN ACID USP DR360MG 1X120T ACC-US EACH DELAYED RELEASE TABLET CONTAINS MYCOPHENOLATE SODIUM, USP	$300.0K	6
PHARM DRUG&MED:MYCOPHENOLIC ACID 360MG-(ACCO-BRZ)-5X10T EACH DELAYED RELEASE COATED TABLET CONT:MYCOPHENOLATE (ASPERINV)	$300.0K	6

Intas Pharmaceuticals Limited exports 220 distinct Mycophenolate formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS AND MEDI MYCOPHENOLATE MOFE with 14 shipments worth $639.4K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Mycophenolate Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	INTAS PHARMACEUTICALS LIMITED ★	$22.7M	454	24	$50.0K
3	ALKEM LABORATORIES LIMITED	$17.8M	356	9	$50.0K
5	EMCURE PHARMACEUTICALS LIMITED	$14.0M	299	23	$46.7K

Intas Pharmaceuticals Limited ranks #1 among 167 Indian Mycophenolate exporters. Average shipment value of $50.0K compared to the market average of $520.1K. The closest competitors by value are ALKEM LABORATORIES LIMITED and EMCURE PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Mycophenolate Exports?

Port	Shipments	% Share
SAHAR AIR	464	18.3%
NHAVA SHEVA SEA (INNSA1)	308	12.2%
SAHAR AIR CARGO ACC (INBOM4)	229	9.1%
JNPT/ NHAVA SHEVA SEA	135	5.3%
DELHI AIR	115	4.5%
AHEMDABAD AIR ACC (INAMD4)	108	4.3%
MUNDRA SEA	97	3.8%
BANGALORE ICD	97	3.8%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Mycophenolate Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Mycophenolate shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 468 individual customs records matching Intas Pharmaceuticals Limited exporting Mycophenolate, covering 220 formulations to 26 countries via 70 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 100+ countries, 512+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Mycophenolate

Mycophenolate

Intas Pharmaceuticals Limited — Mycophenolate Exporter Profile

Intas Pharmaceuticals Limited — Mycophenolate Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Mycophenolate?

Who Are the Top Buyers of Mycophenolate from Intas Pharmaceuticals Limited?

What Is India's Total Mycophenolate Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Mycophenolate Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Mycophenolate Exporters?

What Mycophenolate Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Mycophenolate to Key Markets

United States — FDA

Brazil — ANVISA

How Does Intas Pharmaceuticals Limited Compare to Nearest Mycophenolate Exporters?

Which Indian Ports Ship Mycophenolate Exports?

What Other Immunosuppressants Products Does Intas Pharmaceuticals Limited Export?

Mycophenolate — Export Intelligence Video

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Mycophenolate Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Mycophenolate Export Data from Intas Pharmaceuticals Limited

Mycophenolate Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source